share_log

Maxim Group Upgrades Palisade Bio to Buy, Announces $1.5 Price Target

Benzinga ·  Nov 17, 2023 07:58

Maxim Group analyst Naz Rahman upgrades Palisade Bio (NASDAQ:PALI) from Hold to Buy and announces $1.5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment